Voriconazole in newborns.

Simple item page
dc.contributor.authorKohli, Vikasen_US
dc.contributor.authorTaneja, Vikasen_US
dc.contributor.authorSachdev, Poonamen_US
dc.contributor.authorJoshi, Rajaen_US
dc.date.accessioned2008-03-28en_US
dc.date.accessioned2009-05-27T05:40:27Z
dc.date.available2008-03-28en_US
dc.date.available2009-05-27T05:40:27Z
dc.date.issued2008-03-28en_US
dc.description.abstractVoriconazole is a newer systemic antifungal agent effective against Candida and Aspergillus. There are few reports of its safe use in newborns. We report the first case series of safe Voriconazole use in critically ill newborns with cardiac disease along with several other cardiac drugs without any significant drug interaction or side-effect.en_US
dc.description.affiliationApollo Center for Advanced Pediatrics, Pediatric Cardiology and Cardiac Surgery Unit, Indraprastha Apollo Hospital, New Delhi, India. vkohli_md@yahoo.comen_US
dc.identifier.citationKohli V, Taneja V, Sachdev P, Joshi R. Voriconazole in newborns. Indian Pediatrics. 2008 Mar; 45(3): 236-8en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/12436
dc.language.isoengen_US
dc.source.urihttps://indianpediatrics.neten_US
dc.subject.meshAntifungal Agents --adverse effectsen_US
dc.subject.meshAspergillosis --drug therapyen_US
dc.subject.meshAspergillus --drug effectsen_US
dc.subject.meshCandida --drug effectsen_US
dc.subject.meshCandidiasis --drug therapyen_US
dc.subject.meshCritical Illnessen_US
dc.subject.meshHumansen_US
dc.subject.meshInfant, Newbornen_US
dc.subject.meshPyrimidines --adverse effectsen_US
dc.subject.meshTriazoles --adverse effectsen_US
dc.titleVoriconazole in newborns.en_US
dc.typeCase Reportsen_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Pediatrics